← back to search

Laura Parkkinen

Queen Mary University of London · GB
Area of research
Neurology · Physiology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Alzheimer's disease research and treatments, and Neurological diseases and metabolism.
h-index
39
citations
8,510
works
113
NIH funding
primary concept
email

Recent publications

Robust Immunohistochemical Detection of α-Synuclein, Tau, and β-Amyloid in Human Brain Tissue Archived for up to 78 Years
2026cited by 0position: middledoi
Unraveling microglial spatial organization in the developing human brain with DeepCellMap, a deep learning approach coupled with spatial statistics.
2025cited by 2position: contributordoi
GWAS on short tandem repeats identifies novel genetic mechanisms in Alzheimer’s disease
2025cited by 0position: contributordoi
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes.
2024cited by 13position: contributordoi
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
eLife 2024cited by 12position: lastdoi
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles.
2024cited by 10position: contributordoi
Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease.
2024cited by 4position: contributordoi
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases
2024cited by 1position: contributordoi
Author Correction: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.
2024cited by 1position: contributordoi
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
2024cited by 1position: lastdoi
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
2024cited by 1position: lastdoi
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes
2024cited by 0position: contributordoi
Author response: Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
2024cited by 0position: lastdoi
Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.
2023cited by 43position: contributordoi
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
2023cited by 0position: contributordoi
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
2022cited by 157position: contributordoi
Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
2022cited by 0position: contributordoi
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
Nature Genetics 2021cited by 376position: middledoi
Human-Specific Transcriptome of Ventral and Dorsal Midbrain Dopamine Neurons.
2020cited by 27position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Selene Seoyun Lee · University of Oxford6 papers (2023–2024)Livia Civitelli · University of Oxford5 papers (2023–2024)Melek Firat Altay · King's College London3 papers (2022–2024)Alan King Lun Liu · University of Oxford3 papers (2022–2024)Hilal A. Lashuel · University of Lausanne3 papers (2022–2024)Senthil T. Kumar · Amrita Vishwa Vidyapeetham2 papers (2023–2024)Ilaria Poggiolini · Scuola Internazionale Superiore di Studi Avanzati2 papers (2020–2022)Peter J. Magill · North-West State Technical University2 papers (2024–2024)Stephanie J. Cragg · Hammersmith Hospital2 papers (2024–2024)Shinil Raina · University of Oxford2 papers (2024–2024)Johannes Burtscher · Innsbruck Medical University2 papers (2023–2024)Michael A Lawton · St Michaels Hospital1 papers (2022–2022)Janice L. Holton · University College London1 papers (2022–2022)Poul Henning Jensen · Danish Technological Institute1 papers (2024–2024)Bradley M. Roberts · University of Oxford1 papers (2024–2024)David A. Menassa · University of Oxford1 papers (2025–2025)Rudolph E. Tanzi · The University of Texas Health Science Center at Houston1 papers (2025–2025)T. Lagache · Marine Biological Laboratory1 papers (2025–2025)Xiaofei Li · Qingdao University1 papers (2025–2025)Yana Ruchiy · Karolinska Institutet1 papers (2025–2025)